Kaplan-Meier Estimates for MACE Rates During Follow-Up
Kaplan-Meier estimates for (A) death; (B) death or myocardial infarction; (C) death, myocardial infarction, or target lesion revascularization from discharge onward. Panels on left are for patients with angiographic thrombus and on the right for patients with acute coronary syndrome without angiographic evidence of thrombus. These estimates are adjusted for age, sex, diabetes, hypertension, high cholesterol, smoking history, myocardial infarction within 24 h before percutaneous coronary intervention, myocardial infarction within 1 to 7 days before percutaneous coronary intervention, any history of myocardial infarction >7 days before percutaneous coronary intervention, before percutaneous coronary intervention shock, peripheral vascular disease, primary percutaneous coronary intervention, congestive heart failure, multivessel disease, ejection fraction ≤40%, intra-aortic balloon pump use, history of cerebrovascular accident/transient ischemic attack, tumor/lymphoma/leukemia, chronic renal disease, chronic obstructive pulmonary disease, and medication use (aspirin, beta-blockers, calcium channel blockers, thienopyridines, lipid-lowering agents, and angiotensin-converting enzyme inhibitors. Adjustment was only available in the early stent era for cases from 1994 to 1996. MI = myocardial infarction; TLR = target lesion revascularization; other abbreviations as in Figures 1 and 2.